• Nachrichtendetail
• 

10.06.2024 14:01:53 - dpa-AFX: *ABBOTT GETS FDA CLEARANCE FOR TWO NEW OVER-THE-COUNTER CONTINUOUS GLUCOSE MONITORING SYSTEMS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	Abbott Laboratories	850103	NYSE	109,760	08.08.24 22:00:31	-0,180	-0,16%	109,410	109,840	109,950	109,940